Delving into the Latest Updates on Japan Heart Foundation with Synapse

概览

关联

10

项与 Japan Heart Foundation 相关的临床试验

NCT00454662 / Completed临床4期IIT

Combination of OLMesartan and Calcium Channel Blocker or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

The purpose of this study is to investigate which combination therapy is more effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk hypertensive patients: AT1 subtype angiotensin II receptor antagonist/calcium channel blocker or AT1 subtype angiotensin II receptor antagonist/low dose diuretic.

开始日期2007-04-01

申办/合作机构

Japan Heart Foundation

NCT00294567 / Completed临床4期IIT

Azelnidipine and Amlodipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients Undergoing Coronary Intervention by Serial Volumetric Intravascular Ultrasound Analysis in Junten Medical University (ALPS-J)

In patients with hypertension who undergo elective PCI, the effects of long-term administration of Calblock (azelnidipine) on plaque volume will be determined quantitatively by 3D-IVUS and compared with those of amlodipine besilate (Norvasc or Amlodin).

开始日期2005-12-01

申办/合作机构

Juntendo University

[+1]

NCT00139386 / Completed临床4期IIT

Effects of Candesartan Cilexetil on Cardiovascular Events in Japanese Patients With Hypertension After Sirolimus- or Paclitaxel-Eluting Stents Implantation

Candesartan is effective in preventing cardiovascular events in patients without restenosis after coronary angioplasty. Therefore, the investigators hypothesized that candesartan after drug-eluting stent (DES) implantation was also effective in preventing cardiovascular events.
The purpose of this study is to investigate whether an angiotensin II receptor blocker, candesartan, is effective in reducing the incidence of cardiovascular events after drug-eluting stent implantation.

开始日期2005-10-01

申办/合作机构

Kumamoto University

[+1]

100 项与 Japan Heart Foundation 相关的临床结果

登录后查看更多信息

0 项与 Japan Heart Foundation 相关的专利（医药）

登录后查看更多信息

2

项与 Japan Heart Foundation 相关的文献（医药）

2020-01-01·International Journal of Stroke2区 · 医学

Approval of Stroke and Cardiovascular Disease Control Act in Japan: Comprehensive nationwide approach for prevention, treatment, and patients’ support

2区 · 医学

Article

作者: Yazaki, Yoshio ; Yamaguchi, Takenori ; Isobe, Mitsuaki ; Komuro, Issei ; Nakayama, Hirofumi ; Minematsu, Kazuo ; Miyamoto, Susumu

The Stroke and Cardiovascular Disease Control Act was enacted in Japan in December 2018. This law has become the first ever legislative countermeasure against stroke and cardiovascular disease in Japan. The government shall make a “Basic Plan to Promote Stroke and Cardiovascular Disease Control Programs” with input from a council consisted of stakeholders. In accordance with the government plan, each prefecture shall make a prefectural plan. Both government and prefectural plans will be reviewed at least every six years. A nationwide approach is expected to contribute to reducing the burden of disease and to prolong healthy life expectancy.

2019-08-23·Circulation Journal3区 · 医学

Nationwide Actions Against Heart Failure Pandemic in Japan　― What Should We Do From Academia? ―

3区 · 医学

Review

作者: Isobe, Mitsuaki ; Yazaki, Yoshio ; Morita, Hiroyuki ; Komuro, Issei ; Kaneko, Hidehiro ; Minematsu, Kazuo ; Nakayama, Hirofumi ; Yamaguchi, Takenori

Heart failure pandemic is rapidly approaching in Japan, requiring nationwide actions. In particular, the Japanese Circulation Society and related societies launched the Stroke and Cardiovascular Disease Control Act, which was passed by the National Diet, as the first ever legislative policy measure against stroke and cardiovascular disease. In association with this, actions against heart failure pandemic from the scientific field are also important. Because heart failure pandemic is a critical problem not only in Japan but also in many developed countries, we believe the nationwide approach, as summarized here, will greatly contribute to the development of cardiovascular medicine, particularly the management and treatment of heart failure worldwide.

100 项与 Japan Heart Foundation 相关的药物交易

登录后查看更多信息

100 项与 Japan Heart Foundation 相关的转化医学

登录后查看更多信息